All In Biotech

Drug Trial Radar · NCT03762850

A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy

A Randomized, Multicenter, Double-blind, Parallel-group, Active-control Study of the Efficacy and Safety of Sparsentan for the Treatment of Immunoglobulin A Nephropathy

Last checked: Nov 19, 2026Latest source record: Oct 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 406 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

406

Actual

Start

Dec 11, 2018

Primary completion

Aug 7, 2023

Study completion Aug 19, 2026

Sponsor

Lead sponsor
Travere Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Dec 4, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To determine the long-term (approximately 2 years) nephroprotective potential of treatment with sparsentan as compared to an angiotensin receptor blocker in patients with immunoglobulin A nephropathy (IgAN).

Conditions

  • Immunoglobulin A Nephropathy

Interventions

  • sparsentanDrug

    Target dose of 400 mg daily

  • irbesartanDrug

    Target dose of 300 mg daily

  • DapagliflozinDrug

    Target dose of 10 mg daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent Change From Baseline in the Urine Protein/Creatinine (UP/C) at Week 36Time frame: Baseline (Day 1) and at Week 36

Locations

162 sites in 18 countries. Site status is shown where the registry gives one.

  • Travere Investigational Site

    Birmingham, Alabama

  • Travere Investigational Site

    Homewood, Alabama

  • Travere Investigational Site

    Glendale, California

  • Travere Investigational Site

    Montebello, California

  • Travere Investigational Site

    Northridge, California

  • Travere Investigational Site

    San Diego, California

  • Travere Investigational Site

    San Diego, California

  • Travere Investigational Site

    Stanford, California

  • Travere Investigational Site

    Denver, Colorado

  • Travere Investigational Site

    Coral Springs, Florida

  • Travere Investigational Site

    Hollywood, Florida

  • Travere Investigational Site

    Miami, Florida

  • Travere Investigational Site

    Miami, Florida

  • Travere Investigational Site

    Winter Park, Florida

  • Travere Investigational Site

    Lawrenceville, Georgia

  • Travere Investigational Site

    Nampa, Idaho

  • Travere Investigational Site

    Hinsdale, Illinois

  • Travere Investigational Site

    Muncie, Indiana

  • Travere Investigational Site

    Kansas City, Kansas

  • Travere Investigational Site

    Louisville, Kentucky

  • Travere Investigational Site

    Boston, Massachusetts

  • Travere Investigational Site

    Springfield, Massachusetts

  • Travere Investigational Site

    Worcester, Massachusetts

  • Travere Investigational Site

    Minneapolis, Minnesota

  • Travere Investigational Site

    Reno, Nevada

  • Travere Investigational Site

    Fresh Meadows, New York

  • Travere Investigational Site

    New York, New York

  • Travere Investigational Site

    Cleveland, Ohio

  • Travere Investigational Site

    Columbus, Ohio

  • Travere Investigational Site

    Philadelphia, Pennsylvania

  • Travere Investigational Site

    Columbia, South Carolina

  • Travere Investigational Site

    El Paso, Texas

  • Travere Investigational Site

    Fort Worth, Texas

  • Travere Investigational Site

    Houston, Texas

  • Travere Investigational Site

    Lewisville, Texas

  • Travere Investigational Site

    San Antonio, Texas

  • Travere Investigational Site

    Salt Lake City, Utah

  • Travere Investigational Site

    Salt Lake City, Utah

  • Travere Investigational Site

    Tacoma, Washington

  • Travere Investigational Site

    Marshfield, Wisconsin

Showing 40 of 162 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.